within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonSteroids.M01AH06_Lumiracoxib;

model Lumiracoxib
  extends Pharmacolibrary.Drugs.ATC.M.M01AH06;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>M01AH06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Lumiracoxib is a selective COX-2 inhibitor non-steroidal anti-inflammatory drug (NSAID) formerly used for relief of osteoarthritis and acute pain. It is no longer widely approved due to concerns over hepatotoxicity and has been withdrawn in most markets.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following single oral dose administration.</p><h4>References</h4><ol><li><p>Buvanendran, A, &amp; Barkin, R (2007). Lumiracoxib. <i>Drugs of today (Barcelona, Spain : 1998)</i> 43(3) 137–147. DOI:<a href=&quot;https://doi.org/10.1358/dot.2007.43.3.1062673&quot;>10.1358/dot.2007.43.3.1062673</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17380211/&quot;>https://pubmed.ncbi.nlm.nih.gov/17380211</a></p></li><li><p>Scott, G, et al., &amp; Ruff, DA (2004). Pharmacokinetics of lumiracoxib in plasma and synovial fluid. <i>Clinical pharmacokinetics</i> 43(7) 467–478. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200443070-00003&quot;>10.2165/00003088-200443070-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15139795/&quot;>https://pubmed.ncbi.nlm.nih.gov/15139795</a></p></li><li><p>Rordorf, CM, et al., &amp; Mangold, JB (2005). Clinical pharmacology of lumiracoxib: a selective cyclo-oxygenase-2 inhibitor. <i>Clinical pharmacokinetics</i> 44(12) 1247–1266. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544120-00004&quot;>10.2165/00003088-200544120-00004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16372823/&quot;>https://pubmed.ncbi.nlm.nih.gov/16372823</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Lumiracoxib;
